i-PRO and Vaxtor join forces to deliver powerful edge ALPR Apps on AI-capable cameras
VaxALPR integrated for use on i-PRO AI cameras reduces hardware costs and project complexity. Amsterdam,…
News
Aware’s Knomi Awarded 2022 Future Digital Award for Best Mobile Identity Solution
Award presented by Juniper Research for ability to positively address telecommunications providers’ security challenges BEDFORD,…
Identity Solutions Provider BIO-key Honored with Cybersecurity Excellence Awards in Four Categories
PortalGuard Wins Gold in Multi-factor Authentication, Identity and Access Management, and Single Sign-On Categories; Identity-Bound…
G1 Therapeutics to Provide Fourth Quarter and Full Year 2021 Financial Results and Business Update on February 23, 2022
RESEARCH TRIANGLE PARK, N.C., Feb. 09, 2022 (GLOBE NEWSWIRE) — G1 Therapeutics, Inc. (Nasdaq: GTHX),…
Wave Life Sciences to Present at the Virtual 11th Annual SVB Leerink Global Healthcare Conference 2022
CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage…
Digipath Obtains Coveted Compliance Testing License for California Laboratory
License Provides Steep Hill California Lab with Greatly Expanded Service Offering LAS VEGAS, NV, Feb….
Codex DNA to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
SAN DIEGO, Feb. 09, 2022 (GLOBE NEWSWIRE) — Codex DNA, Inc. (Nasdaq: DNAY), a pioneer…
Pharvaris to Participate in 11th Annual SVB Leerink Global Healthcare Conference
ZUG, Switzerland, Feb. 09, 2022 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a clinical-stage company focused…
4D Molecular Therapeutics Announces Updated Interim Results from the 4D-310 Phase 1/2 Clinical Trial in Patients with Fabry Disease at the 18th Annual WORLDSymposium
Following discontinuation of ERT, AGA activity was stable at 14-fold mean normal level through week…
Athenex to Present at the 11th Annual SVB Leerink Global Healthcare Conference
BUFFALO, N.Y., Feb. 09, 2022 (GLOBE NEWSWIRE) — Athenex, Inc., (NASDAQ: ATNX), a global biopharmaceutical…
89bio to Participate in the SVB Leerink 11ᵗʰ Annual Global Healthcare Conference
SAN FRANCISCO, Feb. 09, 2022 (GLOBE NEWSWIRE) — 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical…
CRISPR Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP),…
Selecta Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference
WATERTOWN, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
Immunovant to Present at the 11th Annual SVB Leerink Global Healthcare Conference
NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
Assembly Biosciences to Present During the SVB Leerink 11th Annual Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
Vincerx Pharma to Participate in the SVB Leerink 11th Annual Global Healthcare Conference
PALO ALTO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical…
Tempest to Present at the 11th Annual SVB Leerink Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — Tempest Therapeutics, Inc. (Nasdaq: TPST),…
Checkmate Pharmaceuticals Appoints Alan Bash as President and CEO
Accomplished global biopharmaceutical executive with over 20 years of strategic and operational leadership at Bristol…
Summit Therapeutics Announces Postponement of Its Planned Rights Offering
Cambridge, Massachusetts, Feb. 09, 2022 (GLOBE NEWSWIRE) — Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or…
RAPT Therapeutics to Participate in the 11th Annual SVB Leerink Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…